CD8A and cancer: In the first pattern, cancer cells have upregulated HLA-I protein expression upon BCG therapy and display increased numbers of CD3+CD8+ T cells in the TME, present a cytotoxic IFN-γ signature, and show T cell checkpoint upregulation.